Medicenna Therapeutics (MDNA) Competitors

Medicenna Therapeutics (TSE:MDNA) and Theratechnologies (TSE:TH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Is MDNA or TH more profitable?

Medicenna Therapeutics has a net margin of 0.00% compared to Theratechnologies' net margin of -29.30%. Medicenna Therapeutics' return on equity of -59.47% beat Theratechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medicenna Therapeutics	N/A	-59.47%	-34.57%
Theratechnologies	-29.30%	-1,116.86%	-6.33%

Which has more volatility and risk, MDNA or TH?

Medicenna Therapeutics has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of MDNA or TH?

7.9% of Medicenna Therapeutics shares are owned by institutional investors. Comparatively, 50.9% of Theratechnologies shares are owned by institutional investors. 23.7% of Medicenna Therapeutics shares are owned by insiders. Comparatively, 6.3% of Theratechnologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has better earnings & valuation, MDNA or TH?

Medicenna Therapeutics has higher earnings, but lower revenue than Theratechnologies. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Theratechnologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicenna Therapeutics	N/A	N/A	-C$15.42M	-C$0.23	-7.13
Theratechnologies	C$81.76M	1.02	-C$23.96M	-C$1.24	-1.46

Does the media favor MDNA or TH?

In the previous week, Theratechnologies had 5 more articles in the media than Medicenna Therapeutics. MarketBeat recorded 5 mentions for Theratechnologies and 0 mentions for Medicenna Therapeutics. Theratechnologies' average media sentiment score of 0.97 beat Medicenna Therapeutics' score of 0.00 indicating that Theratechnologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Medicenna Therapeutics	Neutral
Theratechnologies	Positive

Does the MarketBeat Community prefer MDNA or TH?

Theratechnologies received 181 more outperform votes than Medicenna Therapeutics when rated by MarketBeat users. However, 68.22% of users gave Medicenna Therapeutics an outperform vote while only 63.44% of users gave Theratechnologies an outperform vote.

Company	Underperform	Outperform
Medicenna Therapeutics	Outperform Votes 88 68.22%	Underperform Votes 41 31.78%
Theratechnologies	Outperform Votes 269 63.44%	Underperform Votes 155 36.56%

Do analysts rate MDNA or TH?

Theratechnologies has a consensus price target of C$5.50, suggesting a potential upside of 203.87%. Given Theratechnologies' higher probable upside, analysts clearly believe Theratechnologies is more favorable than Medicenna Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicenna Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Theratechnologies	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Theratechnologies beats Medicenna Therapeutics on 10 of the 16 factors compared between the two stocks.